Landmark trial brings genomic testing to thousands of Ontarians with cancer
The Ontario-wide Cancer Targeted Nucleic Acid Evaluation (OCTANE) expanded the province’s capacity for next-generation sequencing to deliver personalized approaches to treat cancer Maddi was just 33 years old when she learned that her breast cancer had metastasized. She was told the standard-of-care treatment for metastatic breast cancer at the time in 2019 could help manage […]
Read the story
Featured Story